Mounjaro 15 mg/0.6 mL KwikPen 4 Doses

Product Description:

• Mounjaro 15 Mg/0.6ml Kwikpen 4 Doses is a prescription medication used in conjunction with diet and exercise to manage type 2 diabetes.


• It contains tirzepatide, a glucagon-like peptide-1 (GLP-1) receptor agonist.


• Mounjaro helps lower blood sugar levels by increasing insulin production and reducing glucose release from the liver.

How To Use:

• Mounjaro is administered as a weekly subcutaneous injection.


• The recommended starting dose is 2.5 mg, followed by increases of 2.5 mg every four weeks as directed by your doctor.


• The maximum dose is 15 mg per week.

Warnings And Precautions:

• Not for type 1 diabetes or diabetic ketoacidosis.


• May cause thyroid tumors.


• Can lead to pancreatitis.


• Not recommended for pregnant or breastfeeding women.


• May interact with other medications.

Ingredients:

• Active ingredient: Tirzepatide